TNFRSF10B rs1859962: Understanding This Prostate Cancer Variant
The rs1859962 variant is a single nucleotide polymorphism located within the 8q24 gene desert, a region frequently studied for its role in cancer genetics. It is associated with differential susceptibility to prostate cancer, though the evidence remains limited and requires further validation.
What each genotype means
Increased prostate cancer risk
Research indicates that individuals with this genotype may have a statistically higher susceptibility to prostate cancer compared to those with other genotypes. This association is based on population-level studies and does not constitute a medical diagnosis. You should discuss your overall health and family history with a healthcare provider to determine if additional screening is appropriate for you.
This genotype is common in populations of European ancestry, consistent with the reported minor allele frequency of approximately 40%.
Average risk profile
This genotype is generally associated with a baseline or normal risk level for prostate cancer in the context of this specific genetic variant. It does not indicate a significant increase in susceptibility based on current research findings. As with all genetic information, this should be viewed as one small factor among many, including lifestyle and family history.
This is a common heterozygous genotype found frequently across many populations.
Average risk profile
This genotype is generally associated with a baseline or normal risk level for prostate cancer in the context of this specific genetic variant. It does not indicate a significant increase in susceptibility based on current research findings. Please continue to follow standard medical guidelines for prostate health and discuss any concerns with your physician.
This genotype is observed at a frequency consistent with the distribution of the T allele in the general population.
What is rs1859962?
The rs1859962 variant is a specific genetic change, or single nucleotide polymorphism (SNP), located in the human genome. It sits within the 8q24 region, often referred to as an 'oncogenic gene desert.' In genetics, a gene desert is a large segment of DNA that does not contain protein-coding genes but often harbors regulatory elements that control the activity of distant genes. Because rs1859962 is located in a non-coding region, it is believed to influence how nearby genes are turned on or off rather than changing the structure of a protein directly. Researchers study these regulatory variants to understand how subtle differences in our DNA sequence can influence the risk of developing complex diseases, such as prostate cancer, by altering the cellular environment in which these genes operate.
The Role of TNFRSF10B
The rs1859962 variant is associated with the TNFRSF10B gene, which encodes a protein known as Death Receptor 5 (DR5). This protein is a member of the tumor necrosis factor receptor superfamily and plays a critical role in programmed cell death, or apoptosis. When activated by specific ligands, DR5 triggers a signaling cascade that leads to the destruction of damaged or abnormal cells. Because of this function, the gene is sometimes referred to as 'KILLER' or 'TRAIL-R2.' In the context of cancer, the ability of cells to undergo apoptosis is vital for preventing tumor growth. Research has shown that the TNFRSF10B gene can be altered or deleted in certain types of prostate adenocarcinoma, suggesting that its normal function is important for maintaining cellular health and preventing the uncontrolled proliferation characteristic of cancer.
Research and Evidence Strength
The association between rs1859962 and prostate cancer susceptibility is documented in the scientific literature, particularly within the context of genome-wide association studies (GWAS). However, the current evidence strength for this specific variant is considered limited. While the 8q24 region is a well-known hotspot for prostate cancer risk, individual SNPs within this region often show varying degrees of association across different populations. It is important to note that genetic associations are statistical observations, not direct causes. Having a particular genotype does not mean an individual will develop a disease, nor does the absence of a variant guarantee protection. Because the evidence is limited, researchers continue to investigate how this specific SNP interacts with other genetic and environmental factors to influence prostate health.
What You Can Do With This Information
Understanding your genetic profile can be an educational experience, but it is essential to maintain a realistic perspective on what this information means for your health. Genetic variants like rs1859962 are just one small piece of a very large puzzle that includes your lifestyle, environment, and family history. You cannot use this information to diagnose yourself or predict your future health outcomes. If you are concerned about prostate cancer risk, the most effective steps involve regular screenings and discussions with a healthcare professional who can evaluate your overall risk profile. Never make medical decisions based solely on genetic data found in a database. Always consult with a doctor or a genetic counselor to interpret your results in the context of your personal medical history and current clinical guidelines.
How common is this variant?
The minor allele frequency for rs1859962 is approximately 40% in European ancestries, making it a relatively common variant in that population.
Frequently asked questions
Is rs1859962 a direct cause of prostate cancer?
No, rs1859962 is not a direct cause of prostate cancer. It is a genetic marker associated with susceptibility in statistical studies, meaning it may slightly influence risk, but it does not determine whether an individual will develop the disease.
Should I get tested for this SNP?
Routine testing for this specific SNP is not currently recommended for clinical practice. Genetic risk scores are complex, and you should discuss any concerns about prostate cancer screening with your physician based on your age and family history.
What does the 8q24 gene desert do?
The 8q24 gene desert is a region of DNA that does not code for proteins but contains many regulatory elements. These elements act like switches that control the expression of nearby genes, which can influence cancer risk.
How does TNFRSF10B relate to cancer?
TNFRSF10B encodes a protein that helps trigger programmed cell death (apoptosis). In some cancers, the function of this gene is impaired, which may allow abnormal cells to survive and multiply.
Sources & further reading
Educational information only, last refreshed 10/10/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1859962?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29